Singapore - English - HSA (Health Sciences Authority)

acumen research laboratories pte. ltd. - microbiology - the unyvero bcu application used with the unyvero system is a dna test for the simultaneous detection of multiple pathogen-associated nucleic acids in positive blood cultures from patients with signs and symptoms of a bloodstream infection, with the aim of providing information about the pathogen species and antibiotic resistance genes. the identification of specific pathogen dna helps in the diagnosis of these infections caused by bacteria and/or fungi, if these results are used in conjunction with other clinical or laboratory methods. additional cultures are required to cultivate microorganisms for further determination of antibiotic resistance. it is recommended that samples that have tested negative for microorganisms and antibiotic resistance genes with the unyvero bcu application are retested using microbiological cultures. positive findings do not rule out co-infections. the unyvero result should not be used alone for diagnosis and patient management.

Singapore - English - HSA (Health Sciences Authority)

acumen research laboratories pte. ltd. - microbiology - the unyvero hpn application is for use together with the unyvero system. it is used to detect pneumonia-associated pathogens and the antibiotic resistance genes of these pathogens. unyvero hpn application is a dna test based on the parallel execution of eight multiplex pcr reactions. it is for the simultaneous detection of multiple pathogen-associated nucleic acids in sputa, respiratory aspirates and bronchial lavages from patients with suspected pneumonia, with the aim to provide information on pathogen species and antibiotic resistance genes. the identification of specific non-viral pathogen dna in patients with signs and symptoms of pneumonia helps in the diagnosis of respiratory infections caused by bacteria and/or fungi, if these results are used in conjunction with other clinical or laboratory methods. the unyvero result should not be used alone for diagnosis and patient management.

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (immediate release) - 25mg - quetiapine (quetiapine fumarate) 25mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (immediate release) - 100mg - quetiapine (quetiapine fumarate) 100mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (immediate release) - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (immediate release) - 300mg - quetiapine (quetiapine fumarate) 300mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (extended-release) - 50mg - quetiapine (quetiapine fumarate) 50mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (extended-release) - 150mg - quetiapine (quetiapine fumarate) 150mg - atypical antipsychotics

Canada - English - Health Canada

angita pharma inc. - quetiapine (quetiapine fumarate) - tablet (extended-release) - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics